Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	28.62B
Revenue (ttm)	5.95B
Net Income (ttm)	993.59M
Shares Out	354.88M
EPS (ttm)	2.82
PE Ratio	29.40
Forward PE	27.10
Dividend	1.10 (1.36%)
Ex-Dividend Date	Jun 28, 2024

Volume	3,667,742
Average Volume	5,519,921
Open	80.01
Previous Close	83.05
Day's Range	80.01 - 83.43
52-Week Range	59.55 - 94.28
Beta	0.21
RSI	65.75
Earnings Date	Aug 27, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.